Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-10
2007-04-10
Habte, Kahsay (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S217040, C514S217080, C514S217030, C514S217020, C540S597000, C540S596000, C540S602000, C540S604000
Reexamination Certificate
active
10848132
ABSTRACT:
The present invention relates to novel pyridylether derivatives which are cholinergic ligands at nicotinic Ach receptors. The compounds of the invention are useful for the treatment of conditions, disorders, or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse.
REFERENCES:
patent: 4379161 (1983-04-01), Thominet et al.
patent: 4643995 (1987-02-01), Engel et al.
patent: 4667031 (1987-05-01), Lilje
patent: 5034401 (1991-07-01), Frost et al.
patent: 5037841 (1991-08-01), Schohe et al.
patent: 5571815 (1996-11-01), Schaper et al.
patent: 5629325 (1997-05-01), Lin et al.
patent: 6562847 (2003-05-01), Lee
patent: A1-3227741 (1984-01-01), None
patent: A1-4208254 (1993-09-01), None
patent: A1 149088 (1985-07-01), None
patent: A1 338331 (1989-10-01), None
patent: A1 351282 (1990-01-01), None
patent: 829845 (1975-12-01), None
patent: A2 295387 (1996-05-01), None
patent: A1-9728128 (1997-08-01), None
patent: A1-9408992 (1994-04-01), None
patent: A1-9640682 (1996-12-01), None
patent: A1-010997 (2000-03-01), None
patent: WO 96/04266 (1996-02-01), None
patent: W0 9943647 (1999-09-01), None
Sakanoue et al. {Chem. Pharm. Bull. 38(11) 2981-2985 (1990)}.
The Lancet, pp. 1046 (1989).
Merriam et al., Psychiatric Annals 23:4 pp. 171-178 (1993).
Adler et al., Society of Biological Psychiatry pp. Vol. 32 No. 607-616 (1992).
Rowell et al., Journal of Neurochemistry pp. 1593-1598 (1984).
Hall et al., Biochemical Pharmacology, vol. 21, pp. 1829-1838 (1972).
Bourgoin et al., Archives of Pharmacology pp. 91-97 (1976).
Toth et al., Neurochemical Research, vol. 17, No. 3, pp. 265-271 (1992).
Brown et al., Chemical Abstracts, vol. 127:205592 (1997).
Sleevi et al., Chemical Abstracts, vol. 114:185447 (1991).
Kawakita et al., Chemical Abstracts, vol. 112:20993 (1990).
Frost et al., Chemical Abstracts, vol. 113:23913 (1990).
Lilje, Chemical Abstracts, vol. 107:96748 (1987).
Dull et al., Chemical Abstracts, vol. 134:29316 (2000).
Bedell et al., Chemical Abstracts, vol. 134:4752 (2000).
Caille et al., Chemical Abstracts, vol. 133:168383 (2000).
Cale et al., Chemical Abstracts, vol. 109:231085 (1988).
Scheffler et al., Chemical Abstracts, vol. 103:215189 (1985).
Konz et al., Chemical Abstracts, vol. 100:174683 (1994).
Yoshitomi Pharmaceuticals, Chemicals Abstracts, vol. 96:35096 (1982).
Nielsen Elsebet Østergaard
Nielsen Simon F.
Olsen Gunnar M.
Peters Dan
Birch Stewart Kolasch & Birch, LLP.
Habte Kahsay
NeuroSearch A/S
LandOfFree
Pyridylether derivatives, their preparation and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridylether derivatives, their preparation and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridylether derivatives, their preparation and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3760731